Management of Gout

Publisher Website
Google Scholar
Abstract
GRATIFYING developments in the therapy of gout have occurred during the past five years. Until 1950, it was not possible to maintain the serum uric acid at normal levels, prevent urate deposition (tophi) in various body tissues and influence the progressive course of chronic tophaceous gout. With accumulating experience in the continuous use of uricosuric agents, a more hopeful attitude toward the management of the chronic disease has emerged. Under prolonged therapy with these drugs, chronic joint symptoms disappear, tophi regress, acute attacks may be eventually brought under control, serum uric acid can be maintained at or near normal levels . . .
Keywords